Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $22 Price Target

HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $22 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $22 price target.

byBenzinga Newsdesk

March 17, 2023

1 minute read

HC Wainwright & Co. analyst Robert Burns reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $22 price target.

Here’s How Much You Would Have Made Owning Alphabet Stock In The Last 15 Years

By Benzinga Insights

December 23, 11:31 AM

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 15 years by 4.92% on an annualized basis producing…

GOOGL

Analyst Ratings

What 10 Analyst Ratings Have To Say About ONEOK

By Benzinga Insights

May 17, 3:00 PM

ONEOK (NYSE:OKE) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

OKE

JMP Securities Maintains Market Outperform on Intellia Therapeutics, Raises Price Target to $111

By Benzinga Newsdesk

September 19, 8:27 AM

JMP Securities analyst Silvan Tuerkcan maintains Intellia Therapeutics (NASDAQ:NTLA) with a Market Outperform and raises the price target from $106 to $111.

NTLA

Coinbase Shares Are Surging: What’s Going On?

By Vaishali Prayag

June 4, 2:19 PM

Coinbase Global Inc. (NASDAQ:COIN) shares are moving higher Tuesday afternoon, coinciding with upward movement in the price of Bitcoin (CRYPTO: BTC).

BTC

HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $22 Price Target

Related Posts

Here’s How Much You Would Have Made Owning Alphabet Stock In The Last 15 Years

What 10 Analyst Ratings Have To Say About ONEOK

JMP Securities Maintains Market Outperform on Intellia Therapeutics, Raises Price Target to $111

Coinbase Shares Are Surging: What’s Going On?